Biocryst Pharmaceuticals reported $2.57B in Market Capitalization for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Adamas Pharmaceuticals ADMS:US 223.88M 15.88M
Alexion Pharmaceuticals ALXN:US $ 33.78B 393.15M
Alnylam Pharmaceuticals ALNY:US $ 22.44B 2.51B
Biocryst Pharmaceuticals BCRX:US $ 2.57B 239.02M
Chemocentryx CCXI:US $ 1.2B 261.4M
Chugai Pharma 4519:JP 6889.17B 502.04B
Daiichi Sankyo 4568:JP 5801.19B 1139.01B
Dbv Technologies DBVT:US 550.75M 53.79M
Enanta Pharmaceuticals ENTA:US $ 1.15B 259.62M
Gilead Sciences GILD:US $ 87.58B 1.22B
Glaxosmithkline GSK:US 95.15B 3.61B
GlaxoSmithKline GSK:LN 70.63B 794.04M
Intra Cellular Therapies ITCI:US $ 3.03B 286.74M
IONIS PHARMACEUT IONS:US $ 4.73B 888.92M
Karyopharm Therapeutics KPTI:US $ 439.39M 335.56M
Mirati Therapeutics MRTX:US $ 9.13B 823.57M
Neurocrine Biosciences NBIX:US $ 9.08B 123.68M
Novavax NVAX:US $ 15.44B 289.68M
Ptc Therapeutics PTCT:US $ 2.63B 355.33M
Regeneron Pharmaceuticals REGN:US $ 64.73B 5.23B
Sarepta Therapeutics SRPT:US $ 7.38B 1.18B
Ultragenyx Pharmaceutical RARE:US $ 6.12B 316.34M
Vertex Pharmaceuticals VRTX:US $ 47.06B 5.14B
YTE INCY:US $ 15.19B 3.31B
Zogenix ZGNX:US $ 849.09M 115.36M